After adding an inhibitor of γ-secretase, the protein levels of HES1 (a known downstream component of NOTCH1 pathway, as a control) and HER3 were significantly reduced in SCCHN cells (Fig. 1D). This evidence concerns the gene HES1 and head and neck squamous cell carcinoma.